SecBot SecBot
SECBOTREPLAY Home › Report › TNDM

TNDM · GS discloses 5.9% passive stake

TANDEM DIABETES CARE INC · SC 13G filed Nov 9, 2026 at 20:40 ET

At the news

NEUTRALIMPACT 4/10

SC 13G filed Nov 9, 2026 at 20:40 ET

Goldman Sachs Group disclosed a 5.9% passive stake in Tandem Diabetes Care as of September 30, 2026, holding approximately 4.09 million shares. This is a new 13G filing by Goldman Sachs, which had not previously reported a 5%+ position in TNDM. The filing comes shortly after Tandem's Q3 2026 earnings beat consensus estimates, with revenue up 14% YoY and a narrower operating loss.

  • Goldman Sachs Group reported beneficial ownership of 4,091,935 shares of Tandem Diabetes Care common stock, representing 5.9% of shares outstanding as of September 30, 2026.
  • The filing is a Schedule 13G, certifying passive intent with no purpose or effect of changing or influencing control of the issuer.
  • Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, is the direct holder; Goldman Sachs Group is the parent holding company.
  • This is a new 13G filing by Goldman Sachs; no prior 13G or 13D from this filer appears in the cross-filing context.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access